Paratek Pharmaceuticals I... (PRTK)
NASDAQ: PRTK
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM
Paratek Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -62.73M | -65.8M | -63.57M | -88.66M | -85.98M | -58.65M | -59.08M | -51.84M | -54.49M | -87.27M |
Depreciation & Amortization | 308K | 393K | 490K | 482K | 441K | 425K | 391K | 454K | 539K | 618K |
Stock-Based Compensation | 10.34M | 12M | 12.32M | 15.19M | 14.09M | 15.21M | 14.34M | 11.8M | 11.33M | 9.31M |
Other Working Capital | 22.76M | 24.89M | 24M | 34.32M | 33.71M | 30.71M | 29.1M | 11.28M | -1.05M | 4.35M |
Other Non-Cash Items | 4.91M | 4.92M | 5.41M | 7.33M | 6.33M | 5.46M | 4.27M | -1.79M | 370K | -1.65M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.06M | 1.06M | 1.06M |
Change in Working Capital | 23.96M | 12.55M | -20.79M | -179K | 37.97M | -8.31M | -8.19M | -10.94M | -65.23M | -15.63M |
Operating Cash Flow | -23.22M | -35.94M | -66.14M | -65.84M | -27.16M | -45.87M | -48.27M | -52.31M | -107.49M | -94.62M |
Capital Expenditures | -68K | -68K | -72K | -30K | -24K | -141K | -367K | -418K | -464K | -385K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -15.16M | -15.16M | -30.32M | -30.28M | -30.28M | -30.28M | -15.12M | n/a | -9.99M | -9.99M |
Sales Maturities Of Investments | 30M | 30M | 30M | n/a | n/a | n/a | 20M | 47M | 54.5M | 79.5M |
Other Investing Acitivies | 15.2M | 15.2M | 15.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 29.97M | 29.97M | 14.8M | -30.31M | -30.31M | -30.42M | 4.51M | 46.58M | 44.04M | 69.12M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.57M | 1.72M | 5.09M | 12.11M | 21.55M | 21.82M | 18.33M | 13.16M | -5.22M | 1.85M |
Financial Cash Flow | -3.57M | 1.72M | 5.09M | 12.11M | 21.55M | 21.82M | 18.33M | 13.16M | -5.22M | 1.85M |
Net Cash Flow | 3.18M | -4.26M | -46.24M | -84.04M | -35.92M | -54.47M | -25.43M | 7.43M | -68.67M | -23.64M |
Free Cash Flow | -23.29M | -36.01M | -66.21M | -65.87M | -27.18M | -46.01M | -48.64M | -52.73M | -107.96M | -95M |